Molecular Biomarkers Associated With Degenerative Joint Disease in the Knee

This study has been completed.
Sponsor:
Collaborator:
Stanford University
Information provided by:
Scuderi, Gaetano J., M.D.
ClinicalTrials.gov Identifier:
NCT01006278
First received: October 30, 2009
Last updated: NA
Last verified: October 2009
History: No changes posted
  Purpose

This investigation describes a novel complex of structural degradation proteins that is associated with pain in individuals with meniscal pathology undergoing arthroscopic partial meniscectomy. The presence of the complex in the synovial fluid of the knee is sensitive and specific for the painful state compared with similar aged controls. The absence of the complex in asymptomatic controls makes it a useful biomarker for the disease state.


Condition
Cartilage Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Biomarkers Associated With Degenerative Joint Disease

Resource links provided by NLM:


Further study details as provided by Scuderi, Gaetano J., M.D.:

Biospecimen Retention:   Samples Without DNA

synovial fluid ananysis


Enrollment: 40
Study Start Date: January 2008
Study Completion Date: March 2009
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
Surgical group with knee pain
patients 18 years of age or greater with a history of knee pain for more than three but less than six months who failed conservative management with the presence of mechanical symptoms including locking, catching, or giving way; positive physical exam findings including joint line tenderness, McMurray's exam, or Steinman's exam; and MRI of the knee positive for meniscus tear in a location correlating with physical examination. Exclusion criteria were as follows: the presence of high grade gonarthrosis including Kellgren-Lawrence grade IV; a history of prior knee surgery or trauma; ligamentous incompetence on examination or MRI; and diagnosis of inflammatory arthritides, crystalline arthropathies, or other rheumatologic diseases.
Group 2
volunteer group

Detailed Description:

Background: Molecular biomarkers associated with knee pain may be useful as diagnostic tools, prognostic indicators, and surrogate endpoints for therapeutic trials. This study describes a novel complex of structural degradation proteins which are present in the knees of patients with meniscal pathology.

Methods: This prospective cohort study included 30 patients with knee pain, mechanical symptoms, and MRI positive for meniscus tear who elected for arthroscopic partial meniscectomy after failing conservative management. Synovial fluid was aspirated at the time of surgery and assayed for a complex of structural degradation proteins by means of heterogeneous ELISA. The results were compared to knee aspirates from 10 asymptomatic volunteers with no pain. The complex was identified by a proteomic analysis of including multiplexed-bead immunoassay, purification by anion exchange and size exclusion chromatography, and mass spectrometry of individual chromatographic fractions.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The operative group consisted of patients 18 years of age or greater with a history of knee pain for more than three but less than six months who failed conservative management including NSAIDs, physical therapy, and activity modification.

Criteria

Inclusion Criteria:

  • the presence of mechanical symptoms including locking, catching, or giving way;
  • positive physical exam findings including joint line tenderness, McMurray's exam, or Steinman's exam; and
  • MRI of the knee positive for meniscus tear in a location correlating with physical examination.

Exclusion Criteria:

  • the presence of high grade gonarthrosis including Kellgren-Lawrence grade IV;
  • a history of prior knee surgery or trauma; ligamentous incompetence on examination or MRI; and
  • diagnosis of inflammatory arthritides, crystalline arthropathies, or other rheumatologic diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01006278

Sponsors and Collaborators
Scuderi, Gaetano J., M.D.
Stanford University
Investigators
Principal Investigator: Gaetano J Scuderi, MD Stanford University
  More Information

No publications provided

Responsible Party: Gaetano J Scuderi, MD, Stanford University
ClinicalTrials.gov Identifier: NCT01006278     History of Changes
Other Study ID Numbers: Cyt.002
Study First Received: October 30, 2009
Last Updated: October 30, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Scuderi, Gaetano J., M.D.:
biomarker
knee arthroscopy
pain

Additional relevant MeSH terms:
Cartilage Diseases
Joint Diseases
Osteoarthritis
Musculoskeletal Diseases
Connective Tissue Diseases
Arthritis
Rheumatic Diseases

ClinicalTrials.gov processed this record on July 31, 2014